Unifying Mind and Brain: The Transdiagnostic Approach in Neuropsychiatry

The transdiagnostic approach in mental health moves beyond traditional diagnostic categories like those in the DSM and ICD. Instead of focusing on distinct disorders, it seeks to identify shared underlying psychological, cognitive, and neurobiological mechanisms that contribute to a range of mental health difficulties across different diagnoses. This approach suggests that seemingly distinct conditions may share common vulnerabilities or maintaining factors.

In the context of neuropsychiatry, which inherently explores the relationship between brain function and behaviour, the transdiagnostic approach is particularly relevant. Here’s how the transdiagnostic approach impacts neuropsychiatry:

• Focus on Shared Neurobiological Mechanisms: Neuropsychiatry, by its definition, seeks to understand clinical problems through increased knowledge of brain structure and function. The transdiagnostic approach complements this by highlighting that various psychiatric and neurological conditions may share underlying neurobiological mechanisms. Research in neuropsychiatry using a transdiagnostic lens can identify these common neural circuits, genetic factors, or neurochemical imbalances that contribute to a range of symptoms across different diagnostic categories. For instance, disruptions in white matter have been found to be a common alteration in schizophrenia, bipolar disorder, and major depressive disorder. Understanding these shared biological substrates can lead to more unified theories of mental illness.

• Dimensional Understanding of Symptoms: Neuropsychiatry deals with disorders where cognitive, behavioural, or affective disturbances result directly from brain insult or dysfunction. The transdiagnostic approach emphasizes understanding psychopathology along dimensions rather than strict categories. This is highly relevant for neuropsychiatry as neurological conditions often present with a spectrum of neuropsychiatric symptoms that don't fit neatly into DSM or ICD categories. For example, apathy, impulsivity, or cognitive dysfunction can be seen across various neurological conditions like stroke, traumatic brain injury, and neurodegenerative diseases, as well as in traditional psychiatric disorders. A dimensional transdiagnostic approach allows neuropsychiatrists to assess and treat these specific symptom domains directly, irrespective of the primary neurological diagnosis.

• Addressing Comorbidity and Heterogeneity: Neuropsychiatric populations often present with complex comorbidities, where neurological and psychiatric symptoms intertwine. The traditional categorical approach can struggle with this complexity. The transdiagnostic approach acknowledges the high rates of comorbidity and symptom overlap across disorders. This allows neuropsychiatrists to move beyond simply listing co-occurring diagnoses and instead focus on the shared underlying mechanisms driving these symptoms. It also helps address the heterogeneity within diagnostic groups, where individuals with the same diagnosis might have different symptom profiles and underlying neurobiology.

• Informing Diagnosis and Biomarker Discovery: Neuropsychiatry aims to ground psychiatric diagnosis in objective biological markers. The transdiagnostic approach, particularly when combined with neuroimaging and genetic research, can help identify biomarkers that are associated with dimensions of psychopathology that cut across traditional diagnostic boundaries. For example, instead of searching for a biomarker specific to schizophrenia, research might focus on neural correlates of negative symptoms that are present in schizophrenia, autism, and neurodegenerative disorders. Neuroimaging techniques are crucial in this endeavour, allowing for the comparison of brain features across different psychiatric disorders.

• Guiding Treatment Strategies: Most treatment strategies in neuropsychiatry are shared with psychiatry and neurology. A transdiagnostic perspective can inform treatment by targeting shared underlying mechanisms rather than diagnosis-specific symptoms alone. For instance, if emotional dysregulation is identified as a key transdiagnostic process contributing to anxiety and depression in individuals with a neurological condition, a neuropsychiatrist might employ a transdiagnostic approach by managing emotional dysregulation rather than treating several different diagnoses. Furthermore, understanding shared neurobiological deficits can guide the use of psychopharmacological agents that act on common neurotransmitter systems or brain circuits affected across conditions.

• Advancing Research: The transdiagnostic approach, exemplified by initiatives like the Research Domain Criteria (RDoC), encourages research that moves away from traditional diagnostic categories towards investigating fundamental dimensions of functioning across different levels of analysis (e.g., genes, circuits, behaviour). This aligns strongly with the core principles of neuropsychiatry, which seeks to integrate neuroscience into the understanding of mental disorders. Transdiagnostic research in neuropsychiatry can lead to a more biologically informed and clinically relevant classification of mental illnesses, potentially replacing or augmenting the current categorical systems.

In summary, the transdiagnostic approach offers a valuable framework for neuropsychiatry by promoting a focus on shared neurobiological substrates, dimensional symptom assessment, and the development of treatments that target fundamental mechanisms across the spectrum of neurological and psychiatric disorders. This approach has the potential to enhance understanding, diagnosis, and ultimately, the management of complex neuropsychiatric conditions.

Further reading (all open access):

Achenbach, T.M., 2015. Transdiagnostic heterogeneity, hierarchical dimensional models, and societal, cultural, and individual differences in the developmental understanding of psychopathology. Eur. Child Adolesc. Psychiatry 24, 1419–1422. Link to article

Husain, M., 2017. Transdiagnostic neurology: neuropsychiatric symptoms in neurodegenerative diseases. Brain J. Neurol. 140, 1535–1536. Link to article

Li, M., Dahmani, L., Hubbard, C.S., Hu, Y., Wang, M., Wang, D., Liu, H., 2023. Individualized functional connectome identified generalizable biomarkers for psychiatric symptoms in transdiagnostic patients. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 48, 633–641. Link to article

I found almost two thousand papers in my literature search, just over nine hundred with full text available. If you've come across anything interesting about transdiagnostic psychiatry, particularly in relation to neuropsychiatry, pop it in the comments.